Aran Labrijn, PhDDirector, Antibody Research and Technology at Genmab
Dr. Aran F. Labrijn has been working in the field of recombinant antibodies for more than 25 years. He holds a PhD in molecular immunology from the University of Amsterdam (2004). In 2002, he joined Genmab where he is currently a director in the department of antibody research and technology with a focus on understanding antibody biology and Fc-engineering. These studies have led to the development of therapeutic antibody formats, including Genmab’s bispecific antibody technology platform (DuoBody®).